supply of sr phcode 153056 coronary drug eluting stentssr phcode 153056 coronary drug eluting stents,sr phcode 153056 coronary drug eluting stents with (1) stent on cobalt chromi um alloy or platinum chromium alloy. (2) stent with coating of polymer carrier for active d rug ( sirolimus, everolimus or zotarolimus shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter should be from 2.5mm to 4mm and length of the stent from 1 2mm to 38 mm. (4) the strut thickness should be 91 micron or less. (5) stent delivery system should be monorail (single operator exchange or rapid exchange). (6) stent should be comp atible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval should be enclosed in the tender bid. (9) the long term efficacy and safety of the stent in terms of target vessel revascularisation (tvr ) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientific jo urnals.(10) the documents pertaining to the efficacy and safety of the stent should be enc losed for the brand that is offered in the tender bid (11) the manufacturer/supplier shoul d submit proof of supply of the stent to a major government institute. [ warranty period: 30 months after the date of delivery ] ]